Skip to main content
Premium Trial:

Request an Annual Quote

Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test

NEW YORK — Co-Diagnostics said on Friday that it has received CE marking for its Logix Smart SARS-CoV-2 DS.

The PCR-based test is designed to detect the RdRp and E genes of SARS-CoV-2 in minimally processed saliva samples without the need for RNA extraction. The test uses the Salt Lake City-based company's CoPrimer chemistry, which involves attaching primers to probes with a polyethylene glycol-based linker to prevent the formation of primer-dimers.

"The direct saliva technical advance represents one of the important innovations that the company has developed since the [SARS-CoV-2] pandemic began," Co-Diagnostics CEO Dwight Egan said in a statement. "Direct saliva testing will play a key role in our ongoing centralized lab initiative, as well as our forthcoming at-home and point-of-care testing strategies."

SARS-CoV-2 testing has become a major part of Co-Diagnostics' business, accounting for the lion's share of the company's revenues recently.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.